Drugs / Extremecare
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04833998 | Aug 2019 → Nov 2021 | hand-foot syndrome | Instituto Brasileiro de Controle do Cancer | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Extremecare | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04833998 ↗ |
| Route | Topical | “for topical use” NCT04833998 ↗ |